Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus.
Takagi
Tsutomu
T
Takagi Cardiology Clinic, Kyoto, Japan.
Yamamuro
Atsushi
A
Tamita
Koichi
K
Yamabe
Kenji
K
Katayama
Minako
M
Morioka
Shigefumi
S
Akasaka
Takashi
T
Yoshida
Kiyoshi
K
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D002839:Chromans / Q000008:administration & dosage / Q000627:therapeutic use*; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000150:complications* / Q000601:surgery; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000473:pathology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D015607:Stents; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D045162:Thiazolidinediones; D016896:Treatment Outcome; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone